Company: GANX
Filing Date: 2025-11-07
Form Type: S-3/A
Source: 0001104659-25-108472
Chunk: 41

Company: Gain Therapeutics, Inc.
Filing Date: 2025-11-07
Form: S-3/A
Chunk 41
---
 in the case of derivative actions, except that indemnification only extends to expenses (including attorneys’ fees) incurred in connection with defense or settlement of such action, and the statute requires court approval before there can be any indemnification where the person seeking indemnification has been found liable to the corporation. Our Amended Charter and Amended Bylaws contain such a provision. We have in effect a directors and officers liability insurance policy indemnifying our directors and officers for certain liabilities incurred by them, including liabilities under the Securities Act and the Exchange Act. We pay the entire premium of this policy. We have entered into indemnification agreements with each of our directors and officers that provide the maximum indemnity allowed to directors and officers by Section 145 of the DGCL and which allow for certain additional procedural protections.

II-1

TABLE OF CONTENTS

These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification of our officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act. Item 16. Exhibits

| ​ | ExhibitNumber | ​ | ​ | ​                                                                                                                                          | ​ | ​ | ​        | ​ | ​ | ​          | ​ | ​ | Incorporated by Reference |   |   |           | ​ |
| ​ |       Exhibit | ​ | ​ | Form                                                                                                                                       | ​ | ​ | File No. | ​ | ​ | Exhibit    | ​ | ​ |               Filing Date | ​ |   |           |   |
| ​ |        1.1*** | ​ | ​ | Form of Underwriting Agreement                                                                                                             | ​ | ​ | ​        | ​ | ​ | ​          | ​ | ​ |                         ​ | ​ | ​ | ​         | ​ |
| ​ |           3.1 | ​ | ​ | Amended and Restated Certificate of Incorporation of Gain Therapeutics, Inc.                                                               | ​ | ​ | 8-K      | ​ | ​ | 001-40237  | ​ | ​ |                       3.1 | ​ | ​ | 3/17/2021 | ​ |
| ​ |           3.2 | ​ | ​ | Amended and Restated Bylaws of Gain Therapeutics, Inc.                                                                                     | ​ | ​ | 8-K      | ​ | ​ | 001-40237  | ​ | ​ |                       3.2 | ​ | ​ | 3/17/2021 | ​ |
| ​ |           4.1 |